Menu Search
Equities

SQI Diagnostics Inc

SQD.H:NEX

SQI Diagnostics Inc

Actions
  • Price (CAD)0.015
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta-0.4725
Data delayed at least 15 minutes, as of Sep 07 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year SQI Diagnostics Inc had net income fall 75.46% from a loss of 10.56m to a larger loss of 18.52m despite a 783.53% increase in revenues from 917.00k to 8.10m. An increase in the cost of goods sold as a percentage of sales from 16.36% to 61.70% was a component in the falling net income despite rising revenues.
Gross margin10.97%
Net profit margin-628.52%
Operating margin-629.63%
Return on assets-179.74%
Return on equity--
Return on investment--
More ▼

Cash flow in CADView more

In 2022, cash reserves at SQI Diagnostics Inc fell by 959.00k. Cash Flow from Financing totalled 16.36m or 201.89% of revenues. In addition the company used 9.82m for operations while cash used for investing totalled 7.50m.
Cash flow per share-0.0392
Price/Cash flow per share--
Book value per share-0.035
Tangible book value per share-0.0356
More ▼

Balance sheet in CADView more

SQI Diagnostics Inc appears to have a weak balance sheet, highlighted by its negative owner's equity. Additionally, this company's debt load is greater than its assets while day-to-day operations are losing money.
Current ratio0.1253
Quick ratio0.1193
Total debt/total equity--
Total debt/total capital24.07
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.